Frontiers in Immunology (Dec 2023)
Commentary: PFKFB3 overexpression in monocytes of patients with colon but not rectal cancer programs pro-tumor macrophages and is indicative for higher risk of tumor relapse
Abstract
No abstracts available.Keywords